BOTH OF THE NATION’S LARGEST clinical laboratory companies reported increased specimen volume as a result of the Accountable Care Act (ACA), as noted in their respective fourth quarter and full-year earnings reports.
- Dark Index
LabCorp, Quest Diagnostics Both Say 2014 Revenue Was Up
Among other factors, the two lab firms attributed the increase in ACA-insured patients as a benefit
- By Robert Michel
- > From the Volume XXII No. 5 - March 30, 2015 Issue
- Tags: accountable care, accountable care act, affordable care act, Anatomic pathology, clinical lab, clinical laboratories, Clinical Laboratory, days sales outstanding, Esoteric testing, genomics, impac, lab acquisition, lab operation, lab operations, lab test, lab test prices, lab testing, lab testing services, labcorp and quest, labcorp and quest diagnostics, laboratories, laboratory companies, laboratory company, national pathology lab, pathology business, Pathology group, pathology groups, pathology lab, pathology labs, reference laboratories, the affordable care act
